Optimizing drug outcomes through pharmacogenetics: A case for preemptive genotyping

Routine integration of genotype data into drug decision-making could improve patient safety, particularly if many relevant genetic variants can be assayed simultaneously before target drug prescribing. The frequency of pharmacogenetic prescribing opportunities and the potential adverse events (AE) m...

詳細記述

保存先:
書誌詳細
主要な著者: Schildcrout, Jonathan S., Denny, Joshua C., Bowton, Erica, Gregg, William, Pulley, Jill M., Basford, Melissa A., Cowan, James D., Xu, Hua, Ramirez, Andrea H., Crawford, Dana C., Ritchie, Marylyn D., Peterson, Josh F., Masys, Daniel R., Wilke, Russell A., Roden, Dan M.
フォーマット: Artigo
言語:Inglês
出版事項: 2012
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785311/
https://ncbi.nlm.nih.gov/pubmed/22739144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.66
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料